Closed System Transfer Devices Market
Number of pages: 100 | Report Format: PDF | Published date: June 22, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 963.7 million |
|
Revenue Forecast in 2031 |
US$ 4,618.5 million |
|
CAGR |
19.02% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Type, Component, Mechanism, Technology, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global closed system transfer devices market was valued at US$ 963.7 million in 2022 and is expected to register a revenue CAGR of 19.02% to reach US$ 4,618.5 million by 2031.
Closed System Transfer Devices Market Fundamentals
Closed system transfer devices (CSTDs) are specialized devices used in healthcare settings to minimize the risk of exposure to hazardous drugs during the transfer and administration process. These devices are designed to protect healthcare workers, patients, and the environment from the potential harm associated with handling and administering hazardous medications. CSTDs typically consist of components, including vials, syringes, adapters, and connectors, specifically designed to create a closed and leak-proof system. They provide a physical barrier between the drug and the external environment, preventing the release of hazardous substances into the surrounding air and minimizing the potential for contamination.
Closed System Transfer Devices Market Dynamics
There is growing recognition of the occupational hazards associated with handling hazardous drugs, particularly in healthcare settings such as hospitals, clinics, and pharmacies. Concerns about the potential health risks faced by healthcare workers, including nurses, pharmacists, and technicians, have prompted the adoption of CSTDs to mitigate exposure risks. Regulatory agencies and professional organizations, such as OSHA, NIOSH, and USP, have established guidelines and standards for safely handling of hazardous drugs. These regulations emphasize the use of CSTDs as part of comprehensive safety protocols. The need to comply with these guidelines has led to increased adoption of CSTDs across healthcare facilities. The prevalence of cancer and other chronic diseases requiring chemotherapy and other hazardous drug treatments has been on the rise. For instance, according to the 2022 WHO report, non-communicable diseases (chronic diseases) kill nearly 41 million people yearly, equivalent to 74% of all deaths globally. As a result, the demand for CSTDs has increased to ensure the safe preparation, administration, and disposal of these medications, protecting both healthcare workers and patients.
Moreover, patient safety is a paramount concern in healthcare, and using CSTDs contributes to minimizing the risk of medication errors and contamination. By implementing closed drug transfer and administration systems, healthcare providers can enhance patient safety and reduce the potential for adverse events. The CSTD market has witnessed technological advancements and the development of more sophisticated and user-friendly devices. For instance, in March 2022, Simplivia Healthcare Ltd. announced the launch of Chemfort, its newest closed system transfer device. Chemfort reduces the risk of exposure for healthcare professionals when preparing and administering hazardous drugs. These innovations have improved the performance, efficiency, and ease of use of CSTDs, leading to greater acceptance and adoption among healthcare professionals. By ensuring accurate and precise transfer of medications, these devices minimize the loss of expensive drugs and optimize resource utilization. There is a growing emphasis on environmental sustainability in healthcare practices. CSTDs reduce the release of hazardous substances into the environment, minimizing the ecological impact of drug handling and disposal.
There is a lack of uniformity and standardization in CSTD designs and connectors across different manufacturers. This can create challenges when integrating CSTDs into existing medication preparation and administration processes. Incompatibilities between different CSTD systems can lead to inefficiencies and increased costs, as healthcare facilities may need to invest in multiple CSTD technologies to accommodate various drug products. Implementing CSTDs requires training healthcare professionals on proper usage, maintenance, and adherence to safety protocols. Integrating CSTDs into existing workflow processes can also require adjustments and may initially disrupt established routines. Resistance to change and the need for staff education and retraining can pose challenges to the successful implementation of CSTDs. Some CSTDs may have complex designs and require multiple drug preparation and administration steps. Moreover, the limited availability of robust clinical data can challenge convincing healthcare organizations to invest in CSTDs. Regulatory requirements and guidelines for the use of CSTDs vary across countries and regions. Differences in regulatory frameworks can create complexities and inconsistencies in the adoption and implementation of CSTDs globally. Harmonization of regulations and standards across jurisdictions is necessary to facilitate a more consistent and widespread use of CSTDs.
Closed System Transfer Devices Market Ecosystem
The global closed system transfer devices market has been analyzed from the following perspectives: by type, component, mechanism, technology, and region.
Closed System Transfer Devices Market by Type
Based on the type, the global closed system transfer devices market is segmented into membrane-to-membrane systems and needless systems.
Membrane to membrane systems accounts for a sizeable revenue share in the global market. Membrane to membrane systems provide a flexible and versatile solution for drug transfer. These systems typically consist of a membrane-based connection allowing aseptic transfer of medications between various containers, such as vials, syringes, and IV bags. The design of membrane-to-membrane connectors allows compatibility with a wide range of drug containers, accommodating different sizes and shapes. It creates a closed and leak-proof connection between the drug containers, minimizing the risk of drug exposure and contamination. The membrane acts as a physical barrier, preventing the escape of hazardous substances and the entry of contaminants during the transfer process. Membrane-to-membrane systems are generally compatible with a wide range of hazardous drugs, including chemotherapy agents and other toxic medications. This versatility makes them suitable for various clinical applications and reduces the need for multiple transfer devices. Membrane-to-membrane systems enable accurate and precise drug transfer, minimizing medication loss during preparation and administration. By ensuring efficient transfer without spillage or leakage, these systems contribute to reducing medication waste and optimizing resource utilization.
Closed System Transfer Devices Market by Component
Based on the component, the global closed system transfer devices market is segmented into vial access devices, syringe safety devices, bag access devices, and others.
Vial access devices dominate the global market with more than 36.01% of the revenue share. Vial access devices are designed to provide a closed and safe connection to drug vials, allowing for the aseptic transfer of medications. Since drug vials are a common form of medication packaging in healthcare settings, VADs are compatible with a wide range of drugs, including hazardous medications like chemotherapy agents. Vial access devices are generally designed to be user-friendly, with simple connection mechanisms. They are often equipped with features like needleless connectors, luer-lock fittings, or septum-based systems, which make them easy to handle and use. Healthcare professionals can quickly and efficiently transfer medications from vials to other containers without compromising safety. Vial Access Devices can be used with various drug vial sizes, accommodating the different volumes and formulations of medications. Their versatility makes them suitable for different clinical applications and allows healthcare professionals to work with a wide range of drug products.
Closed System Transfer Devices Market by Mechanism
Based on the mechanism, the global closed system transfer devices market is segmented into push to turn systems, color to color alignment systems, click to lock systems, and lueker lock systems.
Color to color alignment system accounts for a prominent revenue share in the global market. Color to color alignment systems use color-coded components to ensure proper alignment and connection between different parts of the CSTD. This visual confirmation can help healthcare professionals quickly and accurately identify compatible components and ensure a secure connection. The color-coding system reduces the risk of errors and improves the overall safety of drug transfer processes. Color to color alignment systems is designed to be user-friendly and intuitive. The color-coded components make it easier for healthcare professionals to identify and match compatible parts, minimizing the potential for misconnections or mistakes during drug transfer. The simplicity of the system allows for efficient and hassle-free operations. Color to color alignment systems is often designed to be compatible with a wide range of CSTD components, such as syringes, vials, and IV bags. This universal compatibility makes the system adaptable to different medication preparation and administration scenarios, reducing the need for multiple transfer devices. Color to color alignment systems offer a standardized component compatibility and connection approach. Continuously using color-coded systems across healthcare facilities can streamline processes, improve workflow efficiency, and reduce the potential for confusion or errors. Standardization also facilitates training and education for healthcare professionals.
Closed System Transfer Devices Market by Technology
Based on the technology, the global closed system transfer devices market is segmented into air filtration devices, compartmentalized devices, and diaphragm based devices.
During the projection period, the revenue growth rate for air cleaning/filtration devices is predicted to be consistent. This is due to the ease of use of these devices, rising concerns for patient and worker safety in handling hazardous drugs, the rising prevalence of chronic diseases, and the need for more effective drug administration methods and better technologies being introduced by major market players worldwide. As demand for safe and effective handling techniques for hazardous pharmaceuticals rises, the air cleaning/filtration devices market is likely to maintain its development trend in the future. This category is well positioned to gain from the general expansion of the market for closed system transfer devices and increased demand for improved air cleaning and filtration technologies.
Closed System Transfer Devices Market by Region
Based on the region, the global closed system transfer devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America has a well-developed healthcare infrastructure, including hospitals, clinics, and pharmacies, committed to implementing the best patient and worker safety practices. These healthcare facilities have the resources and capacity to invest in advanced technologies, including CSTDs, to ensure the safe handling of hazardous drugs. North America is known for its innovation and advancements in healthcare technology. For instance, in December 2021, B. Braun Medical Inc. launched OnGuard 2 CSTD in the United States. OnGuard 2 incorporates all the current advantages of OnGuard while offering upgraded materials and enhanced features to improve its usability. The region has witnessed the development and adoption of advanced CSTD technologies that provide enhanced safety features, user-friendly interfaces, and improved performance. Technological advancements have played a significant role in driving the adoption of CSTDs in North America.
Closed System Transfer Devices Market Competitive Landscape
The prominent players operating in the global closed system transfer devices market are:
Closed System Transfer Devices Market Strategic Developments
Closed system transfer devices (CSTDs) are specialized devices used in healthcare settings to minimize the risk of exposure to hazardous drugs during the transfer and administration process.
Becton, Dickinson and Company, Caragen Ltd., and Baxter International Inc. are some of the major market players in the global closed system transfer devices market.
Limited knowledge and lack of uniformity and standardization are some of the restraints obstructing the growth of the global market.
The vial access devices segment dominated the global closed system transfer devices market in 2022
The rising prevalence of chronic diseases and technological advancement are some of the major factors driving the global market
*Insights on financial performance are subject to the availability of information in the public domain
Recommended Reports